ERA-话题@MedSci

#ERA#

425篇内容 | 6740人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1739031, encodeId=78a31e39031e1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cancer Gene Therapy：肾细胞癌中STAT3调控miR93介导的细胞凋亡 , objectType=article, longId=204405, objectId=067f2044059f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=067f2044059f, replyNumber=0, likeNumber=106, createdTime=2021-05-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=067f2044059f, moduleTitle=Cancer Gene Therapy：肾细胞癌中STAT3调控miR93介导的细胞凋亡 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=067f2044059f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739030, encodeId=55221e39030a7, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Bio-Thera向欧洲药品管理局提交了Avastin生物仿制药BAT1706的营销授权申请（MAA）。, objectType=article, longId=203853, objectId=e1e7203853fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1e7203853fc, replyNumber=0, likeNumber=115, createdTime=2021-01-31, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1e7203853fc, moduleTitle=Bio-Thera向欧洲药品管理局提交了Avastin生物仿制药BAT1706的营销授权申请（MAA）。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1e7203853fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739041, encodeId=035b1e39041ed, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Radiotherapy and Oncology:DNA修复和活性氧水平对胰腺癌放射线抵抗的影响, objectType=article, longId=210456, objectId=0a41210456a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a41210456a7, replyNumber=0, likeNumber=112, createdTime=2021-11-13, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a41210456a7, moduleTitle=Radiotherapy and Oncology:DNA修复和活性氧水平对胰腺癌放射线抵抗的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a41210456a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739025, encodeId=02611e39025d5, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Immunotherapy：微晶酪氨酸相关螨虫提取物免疫疗法治疗过敏性鼻炎的安全性和有效性, objectType=article, longId=200357, objectId=b79720035ede, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b79720035ede, replyNumber=0, likeNumber=83, createdTime=2021-02-15, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b79720035ede, moduleTitle=Immunotherapy：微晶酪氨酸相关螨虫提取物免疫疗法治疗过敏性鼻炎的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b79720035ede)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739036, encodeId=381f1e3903678, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=武田完成向Hypera Pharma出售部分OTC产品和非核心资产, objectType=article, longId=206665, objectId=206820666504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=206820666504, replyNumber=0, likeNumber=130, createdTime=2021-11-04, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=206820666504, moduleTitle=武田完成向Hypera Pharma出售部分OTC产品和非核心资产, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=206820666504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739019, encodeId=5e2a1e390191c, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Nat Cancer：基因检测公司Natera的Signatera ctDNA测试显示出晚期癌症的免疫疗法反应预测能力, objectType=article, longId=198922, objectId=4d22198922b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d22198922b9, replyNumber=0, likeNumber=118, createdTime=2021-03-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d22198922b9, moduleTitle=Nat Cancer：基因检测公司Natera的Signatera ctDNA测试显示出晚期癌症的免疫疗法反应预测能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d22198922b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739022, encodeId=97151e39022bd, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Phytotherapy Research撤稿中国作者8篇论文，皆因实验图片的问题, objectType=article, longId=199875, objectId=48381998e506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48381998e506, replyNumber=0, likeNumber=80, createdTime=2021-06-05, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48381998e506, moduleTitle=Phytotherapy Research撤稿中国作者8篇论文，皆因实验图片的问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48381998e506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739046, encodeId=44cd1e39046f1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alzheimer's Research & Therapy：主观认识功能下降患者默认网络和显著网络功能连接异常预测痴呆, objectType=article, longId=212184, objectId=94ad21218442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94ad21218442, replyNumber=0, likeNumber=109, createdTime=2021-10-12, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94ad21218442, moduleTitle=Alzheimer's Research & Therapy：主观认识功能下降患者默认网络和显著网络功能连接异常预测痴呆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94ad21218442)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739044, encodeId=19481e39044bd, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Eur J Cancer:来那替尼（Neratinib）延伸辅助治疗在HER2/HR共阳性早期乳腺癌患者的疗效和安全性分析：来自德国ExteNET研究的亚组分析结果, objectType=article, longId=211719, objectId=a8bf211e192d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8bf211e192d, replyNumber=0, likeNumber=95, createdTime=2022-01-07, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8bf211e192d, moduleTitle=Eur J Cancer:来那替尼（Neratinib）延伸辅助治疗在HER2/HR共阳性早期乳腺癌患者的疗效和安全性分析：来自德国ExteNET研究的亚组分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8bf211e192d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739038, encodeId=30e11e39038ad, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Molecular Therapy：治一次管3年！基因编辑展现长效降低胆固醇能力, objectType=article, longId=207371, objectId=bc3220e371af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc3220e371af, replyNumber=0, likeNumber=107, createdTime=2022-01-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc3220e371af, moduleTitle=Molecular Therapy：治一次管3年！基因编辑展现长效降低胆固醇能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc3220e371af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739033, encodeId=ebcb1e3903388, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cancer Gene Therapy：CHD1缺失对R0切除的前列腺癌患者的无转移生存产生负面影响并促进体内自发转移, objectType=article, longId=206195, objectId=672220619588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=672220619588, replyNumber=0, likeNumber=94, createdTime=2021-02-17, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=672220619588, moduleTitle=Cancer Gene Therapy：CHD1缺失对R0切除的前列腺癌患者的无转移生存产生负面影响并促进体内自发转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=672220619588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cancer Gene Therapy：LncRNA KCNQ1OT1能够促进膀胱癌进展 , objectType=article, longId=200632, objectId=1834200632f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1834200632f9, replyNumber=0, likeNumber=101, createdTime=2020-12-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1834200632f9, moduleTitle=Cancer Gene Therapy：LncRNA KCNQ1OT1能够促进膀胱癌进展 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1834200632f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739040, encodeId=56201e390409f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Stem Cell Research & Therapy：干细胞与新冠肺炎：人类羊膜细胞是治疗SARS-CoV-2病毒的新希望吗？, objectType=article, longId=208519, objectId=42362085191f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42362085191f, replyNumber=0, likeNumber=108, createdTime=2021-12-17, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42362085191f, moduleTitle=Stem Cell Research & Therapy：干细胞与新冠肺炎：人类羊膜细胞是治疗SARS-CoV-2病毒的新希望吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42362085191f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739028, encodeId=31c01e39028c4, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Vertex和CRISPR Therapeutics的镰状细胞基因疗法已获得PRIME称号, objectType=article, longId=201362, objectId=f56c2013622b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f56c2013622b, replyNumber=0, likeNumber=123, createdTime=2021-06-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f56c2013622b, moduleTitle=Vertex和CRISPR Therapeutics的镰状细胞基因疗法已获得PRIME称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f56c2013622b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739032, encodeId=043d1e390321c, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Oncternal Therapeutics与卡罗林斯卡研究所合作开发靶向ROR1的CAR-T和CAR-NK细胞疗法, objectType=article, longId=205517, objectId=6a4020551e01, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a4020551e01, replyNumber=0, likeNumber=101, createdTime=2021-07-11, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a4020551e01, moduleTitle=Oncternal Therapeutics与卡罗林斯卡研究所合作开发靶向ROR1的CAR-T和CAR-NK细胞疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a4020551e01)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739021, encodeId=fbc91e3902137, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Immunotherapy：3年舌下免疫治疗尘螨诱导过敏性鼻炎效果研究 , objectType=article, longId=199456, objectId=c90419945661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c90419945661, replyNumber=0, likeNumber=101, createdTime=2021-03-16, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c90419945661, moduleTitle=Immunotherapy：3年舌下免疫治疗尘螨诱导过敏性鼻炎效果研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c90419945661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739035, encodeId=c3c01e3903500, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=WCLC 2020：Neratinib治疗EGFR外显子18突变的转移性非小细胞肺癌，II期研究取得相对积极的结果, objectType=article, longId=206509, objectId=3eca206509d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eca206509d2, replyNumber=0, likeNumber=109, createdTime=2021-05-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eca206509d2, moduleTitle=WCLC 2020：Neratinib治疗EGFR外显子18突变的转移性非小细胞肺癌，II期研究取得相对积极的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eca206509d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739016, encodeId=a0ba1e39016cc, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=ERA-EDTA 2020：RNAi疗法公司Alnylam再发力！Lumasiran治疗1型原发性高草酸尿症III期临床成功, objectType=article, longId=195493, objectId=6fc619549390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fc619549390, replyNumber=0, likeNumber=92, createdTime=2020-07-09, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fc619549390, moduleTitle=ERA-EDTA 2020：RNAi疗法公司Alnylam再发力！Lumasiran治疗1型原发性高草酸尿症III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fc619549390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739012, encodeId=7d311e3901239, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Molecular therapy: methods&clinical development：癌症科学家的目标，利用蛋白质的力量来阻止肿瘤的生长, objectType=article, longId=192194, objectId=da78192194f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da78192194f6, replyNumber=0, likeNumber=79, createdTime=2020-07-04, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da78192194f6, moduleTitle=Molecular therapy: methods&clinical development：癌症科学家的目标，利用蛋白质的力量来阻止肿瘤的生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da78192194f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739027, encodeId=fb221e3902774, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, objectType=article, longId=201355, objectId=2779201355ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2779201355ed, replyNumber=0, likeNumber=104, createdTime=2021-06-05, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2779201355ed, moduleTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2779201355ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cancer Gene Therapy：肾细胞癌中STAT3调控miR93介导的细胞凋亡

2021-05-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Bio-Thera向欧洲药品管理局提交了Avastin生物仿制药BAT1706的营销授权申请（MAA）。

2021-01-31

heli0118 (审核中...)

前往app查看评论内容

#ERA#

Radiotherapy and Oncology:DNA修复和活性氧水平对胰腺癌放射线抵抗的影响

2021-11-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Immunotherapy：微晶酪氨酸相关螨虫提取物免疫疗法治疗过敏性鼻炎的安全性和有效性

2021-02-15

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

武田完成向Hypera Pharma出售部分OTC产品和非核心资产

2021-11-04

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Nat Cancer：基因检测公司Natera的Signatera ctDNA测试显示出晚期癌症的免疫疗法反应预测能力

2021-03-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Phytotherapy Research撤稿中国作者8篇论文，皆因实验图片的问题

2021-06-05

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alzheimer's Research & Therapy：主观认识功能下降患者默认网络和显著网络功能连接异常预测痴呆

2021-10-12

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Eur J Cancer:来那替尼（Neratinib）延伸辅助治疗在HER2/HR共阳性早期乳腺癌患者的疗效和安全性分析：来自德国ExteNET研究的亚组分析结果

2022-01-07

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Molecular Therapy：治一次管3年！基因编辑展现长效降低胆固醇能力

2022-01-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cancer Gene Therapy：CHD1缺失对R0切除的前列腺癌患者的无转移生存产生负面影响并促进体内自发转移

2021-02-17

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cancer Gene Therapy：LncRNA KCNQ1OT1能够促进膀胱癌进展

2020-12-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Stem Cell Research & Therapy：干细胞与新冠肺炎：人类羊膜细胞是治疗SARS-CoV-2病毒的新希望吗？

2021-12-17

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Vertex和CRISPR Therapeutics的镰状细胞基因疗法已获得PRIME称号

2021-06-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Oncternal Therapeutics与卡罗林斯卡研究所合作开发靶向ROR1的CAR-T和CAR-NK细胞疗法

2021-07-11

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Immunotherapy：3年舌下免疫治疗尘螨诱导过敏性鼻炎效果研究

2021-03-16

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

WCLC 2020：Neratinib治疗EGFR外显子18突变的转移性非小细胞肺癌，II期研究取得相对积极的结果

2021-05-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

ERA-EDTA 2020：RNAi疗法公司Alnylam再发力！Lumasiran治疗1型原发性高草酸尿症III期临床成功

2020-07-09

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Molecular therapy: methods&clinical development：癌症科学家的目标，利用蛋白质的力量来阻止肿瘤的生长

2020-07-04

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Derazantinib治疗晚期胃癌：即将开展I/II期研究

2021-06-05

科室
- - 订阅+
  - 更多科室
工具
服务